Treasury Inflation-Protected Securities offer a great risk-reward outlook, with PIMCO 15+ Year U.S. TIPS Index ...

The PBoC’s "unreported" purchases in London accounted for a stunning 60 tonnes in September and another 55 tonnes in October.

Read here for more on SMCI stock's struggles with equity or debt options, removal from index, reporting delays, and negative ...

Paycor HCM's new guidance indicates sustainable mid-teens recurring revenue growth. Click here to read why I've upgraded PYCR ...

NervGen's groundbreaking NVG-291 treatment for spinal cord injury is currently in trials with FDA Fast Track Designation.

CareDx has shown strong revenue growth and maintains a robust balance sheet. Read why CDNA stock is a prime candidate for my growth portfolio.

The current fears surrounding Google seem, in my opinion, overly inflated. Click here to read why GOOG stock remains a Buy.

We caution investors on Vistra, highlighting overvaluation despite growth and green initiatives. See why we suggest a hold on ...

Mastercard is a solid long-term investment with strong growth prospects, driven by its global reach and innovative business ...

T. Rowe Price Ultra Short-Term Bond ETF has a 5.3% yield with low volatility and alternative options for minimal ...

Over the course of the last two years, equity investors in the S&P 500 stocks have enjoyed a cumulative price only return of 57.3% ...

NNN REIT's dividend of 5.7% is well-supported by current earnings. Click here to read why growth potential is limited for NNN stock.